Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02923947” into the
search box, and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5160C00035” into the search box, and click “Find a Study”.
Full Trial Title: An Open-label, Non-randomised, Multicentre, Phase I Study to Assess
the Pharmacokinetics, Safety and Tolerability of Osimertinib (TAGRISSO) Following a
Single Oral 80 mg Dose to Patients with Advanced Solid Tumours and Normal Renal
Function or Severe Renal Impairment
AstraZeneca Protocol Number: D5160C00035
AstraZeneca sponsored this study and has its headquarters at
1800 Concord Pike in Wilmington, Delaware.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions
and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 1.8 2019_08_07 8